Clinical trials: Colorectal Carcinoma (CRC)
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
This study is to evaluate the safety, tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with KRAS G12C-mutated solid tumors.
- Conditions
- Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
- Trial name
- NCT06128551
- Testing
- Elironrasib, Daraxonrasib
- Where
- 56 sites in United States, France and 5 more
- Volunteers
- 534 people
- Sponsor
- Revolution Medicines, Inc.
Colorectal Cancer
Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience
over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change.
- Trial name
- NCT06325410
- Testing
- resection of colorectal cancer
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Zagazig University
Colon Cancer, Rectal Cancer
Promoting Physical Activity After Colorectal Cancer
Colorectal cancer is the third most common cancer in the U.S. and if detected early, has a favorable prognosis. Colorectal cancer survivors report increased fatigue, low vigor, impaired physical functioning and disturbances in…
- Trial name
- NCT00230646
- Testing
- Exercise counseling
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- The Miriam Hospital
Colorectal Cancer Metastatic
Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal Cancer
The research will be prospective, randomised, placebo controlled and double-blinded.The research will be carried on with regards to Helsinki Declaration and following the guidelines of Good Clinical Practice.
- Trial name
- Probat-tmcc-17 (NCT03705442)
- Testing
- Omni-Biotic 10, loperamide ("Seldiar")
- Where
- Croatia
- Volunteers
- 76 people
- Sponsor
- Marin Golčić
Colorectal Cancer
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
Spectral CT was used to prospectively collect medical images and clinical data related to colorectal cancer, evaluate the effect of image quality in the diagnosis of colorectal cancer, and evaluate the application value in the…
- Trial name
- NCT06977373
- Testing
- To explore the value of spectral CT in the diagnosis and treatment of colorectal cancer
- Where
- China
- Volunteers
- 150 people
- Sponsor
- Yunnan Cancer Hospital
Colorectal Cancer Metastatic
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Microdevices have been used to ascertain in vivo drug response, which can lead to improved cancer treatment delivery; however, they have not been evaluated for liver tumors.
- Trial name
- NCT07193862
- Testing
- Doxorubicin, FOLFOX, Botensilimab, Balstilimab, Bevacizumab, FOLFIRI, FOLFIRINOX, AGEN2373
- Where
- 2 sites in United States
- Volunteers
- 10 people
- Sponsor
- Northwell Health
Colorectal Cancer
Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Overall survival (OS) remains poor, with 50% estimated 5-year survival.
- Trial name
- NelyCre (NCT05129046)
- Where
- 2 sites in Italy
- Volunteers
- 100 people
- Sponsor
- Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Colorectal Cancer
Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers
Colorectal cancer (CRC) is one of the most common cancers in France (36,000 new cases / year) and nearly 16,000 people die each year from this disease.
- Trial name
- TIL (NCT02557061)
- Testing
- Colorectal surgery (resection), Blood sampling
- Where
- France
- Volunteers
- 56 people
- Sponsor
- University Hospital, Rouen
Metastatic Colorectal Cancer
Local Ablative Strategies After Endovascular Radioembolization
The rationale for this design is initial utilization of a standard-of-care therapy for mCRC (radioembolization) with a dose-calculation algorithm that has been verified as predictive for treatment response.
- Trial name
- LASER (NCT02611661)
- Testing
- PET/MRI, Percutaneous ablation, Stereotactic body radiotherapy
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Washington University School of Medicine
Colon Cancer, Colorectal Cancer
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
The primary objective of this study is to estimate the treatment effect on progression-free survival (PFS) of panitumumab relative to bevacizumab in combination with mFOLFOX6 chemotherapy as first-line therapy in patients with…
- Conditions
- Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer
- Trial name
- NCT00819780
- Testing
- Panitumumab, Bevacizumab, mFOLFOX6
- Where
- 95 sites in United States, Belgium and 4 more
- Volunteers
- 285 people
- Sponsor
- Amgen
Colorectal Cancer
Study on Effect of Robotic Versus Laparoscopic Surgical Technology on Genitourinary Function After Total Mesorectal Excision for Rectal Cancer
Intraoperative pelvic autonomic nerve (PAN) injury is the dominant reason for genitourinary malfunction after total mesorectal excision (TME), particularly in low rectal tumours.
- Trial name
- NCT06409403
- Testing
- clinical application of robotic technique
- Where
- China
- Volunteers
- 164 people
- Sponsor
- general surgery 3
Colorectal Cancer
Expressive Disclosure and Colorectal Cancer
This is a Two-part Pilot Study: Part 1 is descriptive and Part 2 is a pilot randomized trial. Part 1 will be a formative study in which individual interviews are conducted with 20 patients previously diagnosed with colorectal…
- Trial name
- NCT00853203
- Testing
- Interviews, Questionnaires, Electronically Activated Recorder (EAR)
- Where
- 2 sites in United States
- Volunteers
- 174 people
- Sponsor
- M.D. Anderson Cancer Center
Metastatic Colorectal Cancer
Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)
Bevacizumab beyond progression has been proven to be safe in the community setting (BRiTE) and in the post-marketing study (BEAT), and confirmed its efficacy and safety in the first line with all regimens of chemotherapy.
- Trial name
- SAFE (NCT00862342)
- Testing
- Bevacizumab (Avastin)
- Where
- South Korea
- Volunteers
- 78 people
- Sponsor
- Asan Medical Center
Colorectal Cancer, BRAF V600E Mutation Positive
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
This is a pilot trial which aims to assess the concept of anti-BRAF neoadjuvant treatment (encorafenib) in combination with cetuximab in patients with colon cancer or rT3/T4 supra-peritoneal upper rectal cancer based on a…
- Trial name
- NEORAF (NCT05706779)
- Testing
- Encorafenib Oral Capsule + Cetuximab
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Federation Francophone de Cancerologie Digestive
Colorectal Neoplasms
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or…
- Trial name
- OrigAMI-2 (NCT06662786)
- Testing
- Amivantamab, Cetuximab, 5-fluorouracil
- Where
- 239 sites in United States, Belgium and 20 more
- Volunteers
- 1,000 people
- Sponsor
- Janssen Research & Development, LLC
Colorectal Neoplasms, Microbiota
Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.
Colorectal cancer (CRC), second leading cause of cancer worldwide, is associated with a poor prognosis, especially in patients with advanced disease.
- Conditions
- Colorectal Neoplasms, Microbiota, Prognosis, Metabolic Syndrome
- Trial name
- METABIOTE (NCT03843905)
- Testing
- no intervention
- Where
- France
- Volunteers
- 300 people
- Sponsor
- University Hospital, Clermont-Ferrand
Colorectal Cancer
Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer
The primary objective of this open-label phase Ib trial is to determine the maximum tolerated dose and the recommended phase II dose for the combination of PF-03446962 plus regorafenib in patients with metastatic colorectal…
- Trial name
- REGAL-1 (NCT02116894)
- Testing
- PF-03446962, Regorafenib
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Duke University
Primary Care Quality Metrics, Well Child Visits in First 15 Months of Life NQF 1392
The Impact of Patient Complexity on Healthcare Utilization
Healthcare providers are routinely being assessed for metrics designed to assess the quality of the care they deliver. There is growing consensus that these measurements, which typically assess the percentage of patients meeting…
- Conditions
- Primary Care Quality Metrics, Well Child Visits in First 15 Months of Life NQF 1392, Diabetes Mellitus NQF 0059, Colorectal Cancer Screening NQF 0034
- Trial name
- NCT03327896
- Testing
- Charlson score and Community Social Deprivation
- Volunteers
- 200,000 people
- Sponsor
- OCHIN, Inc.
Colorectal Cancer Metastatic
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
This is a multicenter, open label, phase II trial to determine the safety, tolerability, and immunogenicity and initial clinical activity of the combination treatment of PolyPEPI1018 vaccine and atezolizumab in participants with…
- Trial name
- NCT05243862
- Testing
- PolyPEPI1018, Atezolizumab
- Where
- 3 sites in United States
- Volunteers
- 18 people
- Sponsor
- Treos Bio Limited
Colorectal Cancer
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
This study evaluates the relationship of biomarker expression and efficacy of bevacizumab plus chemotherapy in patients with unresectable/metastatic colorectal cancer.
- Trial name
- NCT01679327
- Testing
- Oxaliplatin, Xeloda, Calcium folinate (CF)
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Chinese Academy of Medical Sciences
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.